Inhibitor binding mode and allosteric regulation of Na + -glucose symporters

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-1723

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Inhibitor binding mode and allosteric regulation of Na + -glucose symporters ; volume:9 ; number:1 ; day:7 ; month:12 ; year:2018 ; pages:1-10 ; date:12.2018
Nature Communications ; 9, Heft 1 (7.12.2018), 1-10, 12.2018

Classification: Biowissenschaften, Biologie

Creator: Bisignano, Paola
Ghezzi, Chiara
Jo, Hyunil
Polizzi, Nicholas F.
Althoff, Thorsten
Kalyanaraman, Chakrapani
Friemann, Rosmarie
Jacobson, Matthew P.
Wright, Ernest M.
Grabe, Michael

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-018-07700-1

URN: urn:nbn:de:101:1-2019011922511521140494

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bisignano, Paola
Ghezzi, Chiara
Jo, Hyunil
Polizzi, Nicholas F.
Althoff, Thorsten
Kalyanaraman, Chakrapani
Friemann, Rosmarie
Jacobson, Matthew P.
Wright, Ernest M.
Grabe, Michael
SpringerLink (Online service)

Other Objects (12)

Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors

Orthosteric and allosteric binding sites of P2X receptors

Covalent-allosteric inhibitors to achieve akt isoform-selectivity

Identification of Allosteric Inhibitors against Active Caspase-6

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity

Closantel is an allosteric inhibitor of human Taspase1

Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors

Orthosteric and allosteric binding sites of P2X receptors

Covalent-allosteric inhibitors to achieve akt isoform-selectivity

Identification of Allosteric Inhibitors against Active Caspase-6

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity

Closantel is an allosteric inhibitor of human Taspase1

Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors

Orthosteric and allosteric binding sites of P2X receptors

Covalent-allosteric inhibitors to achieve akt isoform-selectivity

Identification of Allosteric Inhibitors against Active Caspase-6

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity

Closantel is an allosteric inhibitor of human Taspase1

Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Inhibitor binding mode and allosteric regulation of Na + -glucose symporters

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors

Orthosteric and allosteric binding sites of P2X receptors

Covalent-allosteric inhibitors to achieve akt isoform-selectivity

Identification of Allosteric Inhibitors against Active Caspase-6

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity

Closantel is an allosteric inhibitor of human Taspase1

Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors

Orthosteric and allosteric binding sites of P2X receptors

Covalent-allosteric inhibitors to achieve akt isoform-selectivity

Identification of Allosteric Inhibitors against Active Caspase-6

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity

Closantel is an allosteric inhibitor of human Taspase1

Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors

Orthosteric and allosteric binding sites of P2X receptors

Covalent-allosteric inhibitors to achieve akt isoform-selectivity

Identification of Allosteric Inhibitors against Active Caspase-6

Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity

Closantel is an allosteric inhibitor of human Taspase1

Synthesis of an HIV-1 Integrase Allosteric Site Inhibitor

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Bias-inducing allosteric binding site in mu-opioid receptor signaling

Related objects

Reset password